Roche CEO says no plans for job cuts, business healthy, Reuters reports

Swiss pharmaceutical company Roche (RHHBY) is not planning job cuts and its business is healthy, CEO Thomas Schinecker was quoted as saying by a Swiss newspaper on Sunday, according to Reuters. Roche’s share price has fallen far below peaks it scaled in April 2022 and the CEO was questioned about the company’s staffing plans in the context of recent setbacks in its development of drugs to treat cancer, among other illnesses.